Advanced Biomed Inc
NASDAQ:ADVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Advanced Biomed Inc
NASDAQ:ADVB
|
US |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
S
|
SCI Electric PCL
SET:SCI
|
TH |
Intrinsic Value
The intrinsic value of Advanced Biomed Inc (ADVB) under the Base Case is 1.21 USD per share. Compared with the current market price of 2.64 USD, the stock appears Overvalued by 54% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Advanced Biomed Does
Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers.
- Headquarters
- United States of America US
- Employees
- 31
- IPO date
- Mar 6, 2025
Earnings Waterfall
Advanced Biomed Inc
The intrinsic value for Advanced Biomed Inc (ADVB) under the Base Case is 1.21 USD.
Compared with the current market price of 2.64 USD, the stock appears Overvalued by 54% .